Osprey Pharmaceuticals Receives $3,800,000 Series A Round

  • Feed Type
  • Date
    5/27/2009
  • Company Name
    Osprey Pharmaceuticals
  • Mailing Address
    425 California Street San Francisco, CA 94104
  • Company Description
    Osprey Pharmaceuticals USA, together with its Montreal, Canada partner, Osprey Pharmaceuticals, Ltd., is developing a series of novel fusion protein therapeutics which selectively target and neutralize activated leukocytes that are implicated in a variety of inflammatory and immune disorders.
  • Website
    http://www.ospreypharma.com/
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $3,800,000
  • Transaction Round
    Series A
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor
    Burrill & Company
  • Venture Investor
    BDC Venture Capital
  • Venture Investor
    GeneChem
  • Venture Investor
    Western Technology Investment
  • Venture Investor
    Novo Nordisk Biotech Fund
  • Venture Investor
    Yasuda Enterprise Development